Hansoh Pharma starts pre-marketing for $1bn listing
Hansoh Pharmaceutical Group has won approval from the Hong Kong Stock Exchange for a new listing worth up to $1bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: